Cox-2 inhibitor: An antiinflammatory drug that?selectively?blocks the?cox-2?enzyme. Blocking this enzyme impedes the production of the chemical messengers that cause the pain and swelling of arthritis inflammation.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Selective Cox-2 Inhibitors industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Meloxicam
Celecoxib
Etoricoxib
Imrecoxib
Etodolac
Parecoxib
Other
Market Segment by Product Application
Rheumatoid Arthritis
Osteoarthritis
Spondylosis Chronica Ankylopoietica
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Boehringer-Ingelheim
TerSera Therapeutics
Iroko Pharmaceuticals
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Meda Pharmaceuticals
Cipla
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
Almirall Limited
Lupin Pharmaceuticals
Aurobindo Pharma
Pfizer
Mylan
Shire Pharmaceuticals
Bayer
Novacap
Abbott
Geri-Care
Perrigo
Kopran
Merck
Hengrui pharmaceutical
Kelun Group
Qilu Pharmaceutical
Taro Pharmaceuticals
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Selective Cox-2 Inhibitors consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Selective Cox-2 Inhibitors market by identifying its various subsegments.
3.Focuses on the key global Selective Cox-2 Inhibitors manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Selective Cox-2 Inhibitors with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Selective Cox-2 Inhibitors submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Selective Cox-2 Inhibitors Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Selective Cox-2 Inhibitors Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Selective Cox-2 Inhibitors Segment by Type
2.1.1 Meloxicam
2.1.2 Celecoxib
2.1.3 Etoricoxib
2.1.4 Imrecoxib
2.1.5 Etodolac
2.1.6 Parecoxib
2.1.7 Other
2.2 Market Analysis by Application
2.2.1 Rheumatoid Arthritis
2.2.2 Osteoarthritis
2.2.3 Spondylosis Chronica Ankylopoietica
2.2.4 Other
2.3 Global Selective Cox-2 Inhibitors Market Comparison by Regions (2017-2027)
2.3.1 Global Selective Cox-2 Inhibitors Market Size (2017-2027)
2.3.2 North America Selective Cox-2 Inhibitors Status and Prospect (2017-2027)
2.3.3 Europe Selective Cox-2 Inhibitors Status and Prospect (2017-2027)
2.3.4 China Selective Cox-2 Inhibitors Status and Prospect (2017-2027)
2.3.5 Japan Selective Cox-2 Inhibitors Status and Prospect (2017-2027)
2.3.6 Southeast Asia Selective Cox-2 Inhibitors Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Selective Cox-2 Inhibitors Industry Impact
2.5.1 Selective Cox-2 Inhibitors Business Impact Assessment - Covid-19
2.5.2 Market Trends and Selective Cox-2 Inhibitors Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Selective Cox-2 Inhibitors Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Selective Cox-2 Inhibitors Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Selective Cox-2 Inhibitors Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Selective Cox-2 Inhibitors Manufacturer Market Share
3.5 Top 10 Selective Cox-2 Inhibitors Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Selective Cox-2 Inhibitors Market
3.7 Key Manufacturers Selective Cox-2 Inhibitors Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Selective Cox-2 Inhibitors Industry Key Manufacturers
4.1 Boehringer-Ingelheim
4.1.1 Compan Detail
4.1.2 Boehringer-Ingelheim Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.1.3 Boehringer-Ingelheim 178 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Boehringer-Ingelheim News
4.2 TerSera Therapeutics
4.2.1 Compan Detail
4.2.2 TerSera Therapeutics Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.2.3 TerSera Therapeutics Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Boehringer-Ingelheim News
4.3 Iroko Pharmaceuticals
4.3.1 Compan Detail
4.3.2 Iroko Pharmaceuticals Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.3.3 Iroko Pharmaceuticals Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Iroko Pharmaceuticals News
4.4 Apotex
4.4.1 Compan Detail
4.4.2 Apotex Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.4.3 Apotex Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Apotex News
4.5 Yung Shin Pharmaceutical
4.5.1 Compan Detail
4.5.2 Apotex Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.5.3 Yung Shin Pharmaceutical Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Yung Shin Pharmaceutical News
4.6 Breckenridge Pharmaceutical
4.6.1 Compan Detail
4.6.2 Breckenridge Pharmaceutical Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.6.3 Breckenridge Pharmaceutical Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Breckenridge Pharmaceutical News
4.7 Meda Pharmaceuticals
4.7.1 Compan Detail
4.7.2 Meda Pharmaceuticals Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.7.3 Meda Pharmaceuticals Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Cipla
4.8.1 Compan Detail
4.8.2 Cipla Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.8.3 Cipla Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Cipla News
4.9 Glenmark Pharmaceuticals
4.9.1 Compan Detail
4.9.2 Glenmark Pharmaceuticals Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.9.3 Glenmark Pharmaceuticals Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Glenmark Pharmaceuticals News
4.10 Teva
4.10.1 Compan Detail
4.10.2 Teva Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.10.3 Teva Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Teva News
4.11 PuraCap Pharmaceutical
4.11.1 Compan Detail
4.11.2 PuraCap Pharmaceutical Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.11.3 PuraCap Pharmaceutical Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 PuraCap Pharmaceutical News
4.12 Almirall Limited
4.12.1 Compan Detail
4.12.2 Almirall Limited Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.12.3 Almirall Limited Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Almirall Limited News
4.13 Lupin Pharmaceuticals
4.13.1 Company Details
4.13.2 Lupin Pharmaceuticals Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.13.3 Lupin Pharmaceuticals Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Lupin Pharmaceuticals News
4.14 Aurobindo Pharma
4.14.1 Compan Detail
4.14.2 Aurobindo Pharma Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.14.3 Aurobindo Pharma Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Aurobindo Pharma News
4.15 Pfizer
4.15.1 Compan Detail
4.15.2 Pfizer Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.15.3 Pfizer Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Pfizer News
4.16 Mylan
4.16.1 Compan Detail
4.16.2 Mylan Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.16.3 Mylan Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Mylan News
4.17 Shire Pharmaceuticals
4.17.1 Compan Detail
4.17.2 Shire Pharmaceuticals Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.17.3 Shire Pharmaceuticals Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 Shire Pharmaceuticals News
4.18 Bayer
4.18.1 Compan Detail
4.18.2 Bayer Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.18.3 Bayer Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 Bayer News
4.19 Novacap
4.19.1 Compan Detail
4.19.2 Novacap Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.19.3 Novacap Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.19.4 Main Business Overview
4.19.5 Novacap News
4.20 Abbott
4.20.1 Compan Detail
4.20.2 Abbott Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.20.3 Abbott Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.20.4 Main Business Overview
4.20.5 Abbott News
4.21 Geri-Care
4.21.1 Compan Detail
4.21.2 Geri-Care Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.21.3 Geri-Care Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.21.4 Main Business Overview
4.21.5 Geri-Care News
4.22 Perrigo
4.22.1 Compan Detail
4.22.2 Perrigo Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.22.3 Perrigo Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.22.4 Main Business Overview
4.22.5 Perrigo News
4.23 Kopran
4.23.1 Compan Detail
4.23.2 Kopran Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.23.3 Kopran Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.23.4 Main Business Overview
4.23.5 Kopran News
4.24 Merck
4.24.1 Compan Detail
4.24.2 Merck Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.24.3 Merck Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.24.4 Main Business Overview
4.24.5 Merck News
4.25 Hengrui pharmaceutical
4.25.1 Compan Detail
4.25.2 Hengrui pharmaceutical Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.25.3 Hengrui pharmaceutical Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.25.4 Main Business Overview
4.25.5 Hengrui pharmaceutical News
4.26 Kelun Group
4.26.1 Compan Detail
4.26.2 Kelun Group Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.26.3 Kelun Group Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.26.4 Main Business Overview
4.26.5 Kelun Group News
4.27 Qilu Pharmaceutical
4.27.1 Compan Detail
4.27.2 Qilu Pharmaceutical Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.27.3 Qilu Pharmaceutical Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.27.4 Main Business Overview
4.27.5 Qilu Pharmaceutical News
4.28 Taro Pharmaceuticals
4.28.1 Compan Detail
4.28.2 Taro Pharmaceuticals Selective Cox-2 Inhibitors Product Introduction, Application and Specification
4.28.3 Taro Pharmaceuticals Selective Cox-2 Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.28.4 Main Business Overview
4.28.5 Taro Pharmaceuticals News
5 Global Selective Cox-2 Inhibitors Market Segment by Big Type
5.1 Global Selective Cox-2 Inhibitors Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Selective Cox-2 Inhibitors Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Selective Cox-2 Inhibitors Revenue and Market Share by Big Type (2017-2022)
5.2 Meloxicam Sales Growth Rate and Price
5.2.1 Global Meloxicam Sales Growth Rate (2017-2022)
5.2.2 Global Meloxicam Price (2017-2022)
5.3 Celecoxib Sales Growth Rate and Price
5.3.1 Global Celecoxib Sales Growth Rate (2017-2022)
5.3.2 Global Celecoxib Price (2017-2022)
5.4 Etoricoxib Sales Growth Rate and Price
5.4.1 Global Etoricoxib Sales Growth Rate (2017-2022)
5.4.2 Global Etoricoxib Price (2017-2022)
5.5 Imrecoxib Sales Growth Rate and Price
5.5.1 Global Imrecoxib Sales Growth Rate (2017-2022)
5.5.2 Global Imrecoxib Price (2017-2022)
5.6 Etodolac Sales Growth Rate and Price
5.6.1 Global Etodolac Sales Growth Rate (2017-2022)
5.6.2 Global Etodolac Price (2017-2022)
5.7 Parecoxib Sales Growth Rate and Price
5.7.1 Global Parecoxib Sales Growth Rate (2017-2022)
5.7.2 Global Parecoxib Price (2017-2022)
5.8 Other Sales Growth Rate and Price
5.8.1 Global Other Sales Growth Rate (2017-2022)
5.8.2 Global Other Price (2017-2022)
6 Global Selective Cox-2 Inhibitors Market Segment by Big Application
6.1 Global Selective Cox-2 Inhibitors Sales Market Share by Big Application (2017-2022)
6.2 Rheumatoid Arthritis Sales Growth Rate (2017-2022)
6.3 Osteoarthritis Sales Growth Rate (2017-2022)
6.4 Spondylosis Chronica Ankylopoietica Sales Growth Rate (2017-2022)
6.5 Other Sales Growth Rate (2017-2022)
7 Global Selective Cox-2 Inhibitors Forecast
7.1 Global Selective Cox-2 Inhibitors Revenue, Sales and Growth Rate (2022-2027)
7.2 Selective Cox-2 Inhibitors Market Forecast by Regions (2022-2027)
7.2.1 North America Selective Cox-2 Inhibitors Market Forecast (2022-2027)
7.2.2 Europe Selective Cox-2 Inhibitors Market Forecast (2022-2027)
7.2.3 China Selective Cox-2 Inhibitors Market Forecast (2022-2027)
7.2.4 Japan Selective Cox-2 Inhibitors Market Forecast (2022-2027)
7.2.5 Southeast Asia Selective Cox-2 Inhibitors Market Forecast (2022-2027)
7.2.6 Other Regions Selective Cox-2 Inhibitors Market Forecast (2022-2027)
7.3 Selective Cox-2 Inhibitors Market Forecast by Type (2022-2027)
7.3.1 Global Selective Cox-2 Inhibitors Sales Forecast by Type (2022-2027)
7.3.2 Global Selective Cox-2 Inhibitors Market Share Forecast by Type (2022-2027)
7.4 Selective Cox-2 Inhibitors Market Forecast by Application (2022-2027)
7.4.1 Global Selective Cox-2 Inhibitors Sales Forecast by Application (2022-2027)
7.4.2 Global Selective Cox-2 Inhibitors Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Selective Cox-2 Inhibitors Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Selective Cox-2 Inhibitors Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Selective Cox-2 Inhibitors
Figure Market Concentration Ratio and Market Maturity Analysis of Selective Cox-2 Inhibitors
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Selective Cox-2 Inhibitors Market Size by Big Type
Figure Global Market Share of Selective Cox-2 Inhibitors by Big Type in 2021
Figure Meloxicam Picture (2017-2022)
Figure Celecoxib Picture (2017-2022)
Figure Etoricoxib Picture (2017-2022)
Figure Imrecoxib Picture (2017-2022)
Figure Etodolac Picture (2017-2022)
Figure Parecoxib Picture (2017-2022)
Global Selective Cox-2 Inhibitors Market Size by Big Application
Table Global Selective Cox-2 Inhibitors Market Size by Application
Figure Global Selective Cox-2 Inhibitors Market Share by Big Application in 2021
Figure Rheumatoid Arthritis Picture
Figure Osteoarthritis Picture
Figure Spondylosis Chronica Ankylopoietica Picture
Figure Other Picture
Table Global Selective Cox-2 Inhibitors Comparison by Regions (M USD) (2017-2027)
Figure Global Selective Cox-2 Inhibitors Market Size (Million US$) (2017-2027)
Figure North America Selective Cox-2 Inhibitors Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Selective Cox-2 Inhibitors Revenue (Million US$) Growth Rate (2017-2027)
Figure China Selective Cox-2 Inhibitors Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Selective Cox-2 Inhibitors Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Selective Cox-2 Inhibitors Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Selective Cox-2 Inhibitors Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Selective Cox-2 Inhibitors Sales by Manufacturer (2017-2022)
Figure Global Selective Cox-2 Inhibitors Sales Market Share by Manufacturer in 2021
Table Global Selective Cox-2 Inhibitors Revenue by Manufacturer (2017-2022)
Figure Global Selective Cox-2 Inhibitors Revenue Market Share by Manufacturer in 2021
Table Global Selective Cox-2 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Selective Cox-2 Inhibitors Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Selective Cox-2 Inhibitors Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Selective Cox-2 Inhibitors Market
Table Key Manufacturers Selective Cox-2 Inhibitors Product Type
Table Mergers & Acquisitions Planning
Table Boehringer-Ingelheim Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Boehringer-Ingelheim
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table TerSera Therapeutics Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of TerSera Therapeutics
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table TerSera Therapeutics Recent Development
Table Iroko Pharmaceuticals Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Iroko Pharmaceuticals
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Iroko Pharmaceuticals Main Business
Table Iroko Pharmaceuticals Recent Development
Table Apotex Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Apotex
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Apotex Main Business
Table Apotex Recent Development
Table Apotex Main Business
Table Apotex Recent Development
Table Yung Shin Pharmaceutical Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Yung Shin Pharmaceutical
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Yung Shin Pharmaceutical Main Business
Table Yung Shin Pharmaceutical Recent Development
Table Breckenridge Pharmaceutical Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Breckenridge Pharmaceutical
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Breckenridge Pharmaceutical Main Business
Table Breckenridge Pharmaceutical Recent Development
Table Meda Pharmaceuticals Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Meda Pharmaceuticals
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Meda Pharmaceuticals Main Business
Table Meda Pharmaceuticals Recent Development
Table Cipla Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Cipla
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cipla Main Business
Table Cipla Recent Development
Table Glenmark Pharmaceuticals Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Glenmark Pharmaceuticals
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Glenmark Pharmaceuticals Main Business
Table Glenmark Pharmaceuticals Recent Development
Table Teva Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Teva
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva Main Business
Table Teva Recent Development
Table PuraCap Pharmaceutical Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of PuraCap Pharmaceutical
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table PuraCap Pharmaceutical Main Business
Table PuraCap Pharmaceutical Recent Development
Table Almirall Limited Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Almirall Limited
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Almirall Limited Main Business
Table Almirall Limited Recent Development
Table Lupin Pharmaceuticals Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Lupin Pharmaceuticals
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Lupin Pharmaceuticals Main Business
Table Lupin Pharmaceuticals Recent Development
Table Aurobindo Pharma Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Aurobindo Pharma
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Aurobindo Pharma Main Business
Table Aurobindo Pharma Recent Development
Table Mylan Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Mylan
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Mylan Main Business
Table Mylan Recent Development
Table Shire Pharmaceuticals Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Shire Pharmaceuticals
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Shire Pharmaceuticals Main Business
Table Shire Pharmaceuticals Recent Development
Table Bayer Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Bayer
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer Main Business
Table Bayer Recent Development
Table Novacap Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Novacap
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novacap Main Business
Table Novacap Recent Development
Table Abbott Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Abbott
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Abbott Main Business
Table Abbott Recent Development
Table Geri-Care Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Geri-Care
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Geri-Care Main Business
Table Geri-Care Recent Development
Table Perrigo Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Perrigo
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Perrigo Main Business
Table Perrigo Recent Development
Table Kopran Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Kopran
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Kopran Main Business
Table Kopran Recent Development
Table Merck Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Merck
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Hengrui pharmaceutical Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Hengrui pharmaceutical
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hengrui pharmaceutical Main Business
Table Hengrui pharmaceutical Recent Development
Table Kelun Group Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Kelun Group
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Kelun Group Main Business
Table Kelun Group Recent Development
Table Qilu Pharmaceutical Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Qilu Pharmaceutical
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Qilu Pharmaceutical Main Business
Table Qilu Pharmaceutical Recent Development
Table Taro Pharmaceuticals Company Profile
Table Selective Cox-2 Inhibitors Product Introduction, Application and Specification of Taro Pharmaceuticals
Table Selective Cox-2 Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Taro Pharmaceuticals Main Business
Table Taro Pharmaceuticals Recent Development
Figure Global Selective Cox-2 Inhibitors Sales and Growth Rate (2017-2022)
Figure Global Selective Cox-2 Inhibitors Revenue and Growth Rate (2017-2022)
Table Global Selective Cox-2 Inhibitors Sales by Regions (2017-2022)
Figure Global Selective Cox-2 Inhibitors Sales Market Share by Regions in 2021
Table Global Selective Cox-2 Inhibitors Revenue by Regions (2017-2022)
Figure Global Selective Cox-2 Inhibitors Revenue Market Share by Regions in 2021
Figure North America Selective Cox-2 Inhibitors Sales and Growth Rate (2017-2022)
Figure Europe Selective Cox-2 Inhibitors Sales and Growth Rate (2017-2022)
Figure China Selective Cox-2 Inhibitors Sales and Growth Rate (2017-2022)
Figure Japan Selective Cox-2 Inhibitors Sales and Growth Rate (2017-2022)
Figure Southeast Asia Selective Cox-2 Inhibitors Sales and Growth Rate (2017-2022)
Figure Other Regions Selective Cox-2 Inhibitors Sales and Growth Rate (2017-2022)
Table Global Selective Cox-2 Inhibitors Sales by Big Type (2017-2022)
Table Global Selective Cox-2 Inhibitors Sales Market Share by Big Type (2017-2022)
Figure Global Selective Cox-2 Inhibitors Sales Market Share by Big Type in 2019
Table Global Selective Cox-2 Inhibitors Revenue by Big Type (2017-2022)
Table Global Selective Cox-2 Inhibitors Revenue Market Share by Big Type (2017-2022)
Table Global Selective Cox-2 Inhibitors Revenue Market Share by Big Type in 2019
Figure Global Meloxicam Sales Growth Rate (2017-2022)
Figure Global Meloxicam Price (2017-2022)
Figure Global Celecoxib Sales Growth Rate (2017-2022)
Figure Global Celecoxib Price (2017-2022)
Figure Global Etoricoxib Sales Growth Rate (2017-2022)
Figure Global Etoricoxib Price (2017-2022)
Figure Global Imrecoxib Sales Growth Rate (2017-2022)
Figure Global Imrecoxib Price (2017-2022)
Figure Global Parecoxib Sales Growth Rate (2017-2022)
Figure Global Parecoxib Price (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Table Global Selective Cox-2 Inhibitors Sales by Big Application (2017-2022)
Table Global Selective Cox-2 Inhibitors Sales Market Share by Big Application (2017-2022)
Figure Global Selective Cox-2 Inhibitors Sales Market Share by Big Application in 2019
Figure Global Rheumatoid Arthritis Sales Growth Rate (2017-2022)
Figure Global Osteoarthritis Sales Growth Rate (2017-2022)
Figure Global Spondylosis Chronica Ankylopoietica Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Selective Cox-2 Inhibitors Sales and Growth Rate (2022-2027)
Figure Global Selective Cox-2 Inhibitors Revenue and Growth Rate (2022-2027)
Table Global Selective Cox-2 Inhibitors Sales Forecast by Regions (2022-2027)
Table Global Selective Cox-2 Inhibitors Market Share Forecast by Regions (2022-2027)
Figure North America Sales Selective Cox-2 Inhibitors Market Forecast (2022-2027)
Figure Europe Sales Selective Cox-2 Inhibitors Market Forecast (2022-2027)
Figure China Sales Selective Cox-2 Inhibitors Market Forecast (2022-2027)
Figure Japan Sales Selective Cox-2 Inhibitors Market Forecast (2022-2027)
Figure Southeast Asia Sales Selective Cox-2 Inhibitors Market Forecast (2022-2027)
Figure Other Regions Sales Selective Cox-2 Inhibitors Market Forecast (2022-2027)
Table Global Selective Cox-2 Inhibitors Sales Forecast by Type (2022-2027)
Table Global Selective Cox-2 Inhibitors Market Share Forecast by Type (2022-2027)
Table Global Selective Cox-2 Inhibitors Sales Forecast by Application (2022-2027)
Table Global Selective Cox-2 Inhibitors Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Selective Cox-2 Inhibitors
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Selective Cox-2 Inhibitors Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Selective Cox-2 Inhibitors Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Selective Cox-2 Inhibitors Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Selective Cox-2 Inhibitors Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Selective Cox-2 Inhibitors Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Selective Cox-2 Inhibitors Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Selective Cox-2 Inhibitors Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Selective Cox-2 Inhibitors Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Boehringer-Ingelheim
TerSera Therapeutics
Iroko Pharmaceuticals
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Meda Pharmaceuticals
Cipla
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
Almirall Limited
Lupin Pharmaceuticals
Aurobindo Pharma
Pfizer
Mylan
Shire Pharmaceuticals
Bayer
Novacap
Abbott
Geri-Care
Perrigo
Kopran
Merck
Hengrui pharmaceutical
Kelun Group